# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-22-007543
Filing Date
2022-03-29
Accepted
2022-03-29 16:06:11
Documents
120
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | nby20211231b_10k.htm iXBRL | 10-K | 2324796
2 | EXHIBIT 3.7 | ex_351428.htm | EX-3.7 | 197401
3 | EXHIBIT 4.1 | ex_343782.htm | EX-4.1 | 15947
4 | EXHIBIT 10.1 | ex_346224.htm | EX-10.1 | 76282
5 | EXHIBIT 10.15 | ex_346225.htm | EX-10.15 | 17564
6 | EXHIBIT 21 | ex_348186.htm | EX-21 | 2438
7 | EXHIBIT 23.1 | ex_343783.htm | EX-23.1 | 2639
8 | EXHIBIT 23.2 | ex_350338.htm | EX-23.2 | 2614
9 | EXHIBIT 31.1 | ex_343784.htm | EX-31.1 | 8361
10 | EXHIBIT 31.2 | ex_343785.htm | EX-31.2 | 8486
11 | EXHIBIT 32.1 | ex_343786.htm | EX-32.1 | 4276
12 | EXHIBIT 32.2 | ex_343787.htm | EX-32.2 | 4272
18 |  | logo01.jpg | GRAPHIC | 9343
| Complete submission text file | 0001437749-22-007543.txt |  | 12405850

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20211231.xsd | EX-101.SCH | 125531
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20211231_cal.xml | EX-101.CAL | 86785
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20211231_def.xml | EX-101.DEF | 774895
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20211231_lab.xml | EX-101.LAB | 659630
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20211231_pre.xml | EX-101.PRE | 820214
114 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20211231b_10k_htm.xml | XML | 2070240

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 22780814
SIC: 2834 Pharmaceutical Preparations